Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Arad

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Prostaglandins & Other Lipid Mediators|June 12, 2016
The role of 20-HETE in cardiovascular diseases and its risk factorsMaayan Waldman, Stephen J Peterson, Michael Arad, et al.
Antioxidants & Redox Signaling|February 7, 2020
The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic CardiomyopathyMaayan Waldman, Michael Arad, Nader G Abraham, et al.
Clinical Cardiology|September 20, 2014
Predictors and outcome of sustained improvement in left ventricular function in dilated cardiomyopathyIdo Blechman, Michael Arad, Tamar Nussbaum, et al.
Journal of Clinical Medicine|July 27, 2022
The Prognostic Role of Mitral Valve Regurgitation Severity and Left Ventricle Function in Acute Heart FailureIsrael Mazin, Michael Arad, Dov Freimark, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|October 26, 2012
A family with recurrent sudden death and no clinical clueMichael Arad, Michael Glikson, Dalia El-Ani, et al.
Blood Purification|May 29, 2013
Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factorsMargarita Kunin, Michael Arad, Dganit Dinour, et al.
Life Sciences|May 24, 2011
Rapamycin (sirolimus) protects against hypoxic damage in primary heart cultures via Na+/Ca2+ exchanger activationDalia El-Ani, Hagit Stav, Victor Guetta, et al.
Harefuah|November 10, 2007
[AMP-activated protein kinase: how a mistake in energy gauge causes glycogen storage]Michal Ofir, Edith Hochhauser, Bernardo A Vidne, et al.
European Journal of Heart Failure|May 2, 2009
Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failureMichael Shechter, Shlomi Matetzky, Michael Arad, et al.
International Journal of Cardiology. Heart & Vasculature|July 25, 2022
The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccineYishay Wasserstrum, Sofia Nadav, Amitai Segev, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Prostaglandins & Other Lipid Mediators|June 12, 2016
The role of 20-HETE in cardiovascular diseases and its risk factorsMaayan Waldman, Stephen J Peterson, Michael Arad, et al.
Antioxidants & Redox Signaling|February 7, 2020
The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α-Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic CardiomyopathyMaayan Waldman, Michael Arad, Nader G Abraham, et al.
Clinical Cardiology|September 20, 2014
Predictors and outcome of sustained improvement in left ventricular function in dilated cardiomyopathyIdo Blechman, Michael Arad, Tamar Nussbaum, et al.
Journal of Clinical Medicine|July 27, 2022
The Prognostic Role of Mitral Valve Regurgitation Severity and Left Ventricle Function in Acute Heart FailureIsrael Mazin, Michael Arad, Dov Freimark, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|October 26, 2012
A family with recurrent sudden death and no clinical clueMichael Arad, Michael Glikson, Dalia El-Ani, et al.
Blood Purification|May 29, 2013
Peritoneal dialysis in patients with refractory congestive heart failure: potential prognostic factorsMargarita Kunin, Michael Arad, Dganit Dinour, et al.
Life Sciences|May 24, 2011
Rapamycin (sirolimus) protects against hypoxic damage in primary heart cultures via Na+/Ca2+ exchanger activationDalia El-Ani, Hagit Stav, Victor Guetta, et al.
Harefuah|November 10, 2007
[AMP-activated protein kinase: how a mistake in energy gauge causes glycogen storage]Michal Ofir, Edith Hochhauser, Bernardo A Vidne, et al.
European Journal of Heart Failure|May 2, 2009
Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failureMichael Shechter, Shlomi Matetzky, Michael Arad, et al.
International Journal of Cardiology. Heart & Vasculature|July 25, 2022
The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccineYishay Wasserstrum, Sofia Nadav, Amitai Segev, et al.
Pageof 15